Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Conditions

Prostatic Neoplasms 28Leiomyoma 5Endometriosis 3Prostate Adenocarcinoma 2Pregnancy Complications 2Myofibroma 2Adenocarcinoma 2Uterine Neoplasms 1Uterine Hemorrhage 1Pathologic Complete Response 1Neoplasm, Residual 1Neoplasm Metastasis 1Myoma 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-Resistant Prostate Cancer 1Menorrhagia 1

Interventions

relugolix 2Uterine Myomectomy 1Norethindrone Acetate 1Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pregnancy Complications × relugolix × 1 year × Clear all
NCT05739123 2025-08-19

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Sumitomo Pharma Switzerland GmbH

Recruiting
728 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

NCT05739136 2025-08-01

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland GmbH

Active not recruiting
530 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡